# Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue

> **NCT01319916** · PHASE1 · COMPLETED · sponsor: **Kythera Biopharmaceuticals** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ATX-101

## Key facts

- **NCT ID:** NCT01319916
- **Lead sponsor:** Kythera Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2011-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01319916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01319916, "Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01319916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*